Advisor Website Home | Contact Us | Site Map | Help | Career Opportunities

Detailed Fund Information

SMALLCAP World Fund® (growth fund)

Class F-2 shares

Select a fund and share class

How do the share classes differ?

Daily Prices

Updated April 16, 2014, 3:11PM Pacific time

Net Asset Value (NAV) $48.44
NAV Change $0.47

(All prices are subject to revision.)

Historical Prices & Distributions

Choose a date

Ticker Symbols & Fund Numbers

Fund Number 635
Ticker/Quotron Symbol SMCFX
CUSIP Number 831681 82 0

Fund Description

Fund Objective The fund's investment objective is to provide long-term growth of capital.
Distinguishing Characteristics One of few small-company growth funds that invests globally. Normally, at least 80% of assets will be invested in equities of issuers having market capitalizations of $4 billion or less, measured at time of purchase.
Types of Investments The fund invests primarily in common stocks, government and corporate debt, and cash and equivalents.
Non-U.S. Holdings There is no specific limit. Historically, the fund has invested a substantial portion of assets in the U.S. because of the number of small-cap opportunities.

Fund Facts

Minimum Initial Investment $250
Shareholder Accounts (aggregated for all share classes; updated monthly) 1,916,649
Regular Dividends Paid December
Capital Gains Paid December
Fund Inception April 30, 1990
Fiscal Year-End September

The months indicated for dividends and capital gains paid represent the anticipated current year ex-dividend date schedule for all share classes.

Returns & Expenses

Figures shown are past results and are not predictive of results in future periods. Current and future results may be lower or higher than those shown. Results shown at net asset value have all distributions reinvested. If a sales charge had been deducted, the results would have been lower. Share price and return will vary, so investors may lose money. Investing for short periods makes losses more likely. Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value. Definitions and other important legal information about these prices and returns are shown below.

Rates of Return*

  Average Annual Total Returns
1 yr 3 yrs 5 yrs 10 yrs Fund Lifetime
March 31, 2014 (most recent month-end)
NAV 20.32% 10.32% 23.16% 9.64% 10.29%
March 31, 2014 (most recent quarter-end)
NAV 20.32% 10.32% 23.16% 9.64% 10.29%

Expense Ratios

SMALLCAP World Fund 0.82%
Lipper Global Small-/Mid-Cap Funds Average 1.30%

12-Month Distribution Rates

As of March 31, 2014 (updated monthly)

NAV 0.00%

Annualized 30-Day SEC Yield

As of March 31, 2014 (updated monthly)

At net asset value 0.11%

Holdings

Largest Industry Holdings

% of net assets as of March 31, 2014 (updated quarterly)

Biotechnology 6.4%
Hotels, restaurants & leisure 5.0%
Oil, gas & consumable fuels 4.1%
Internet & catalog retail 3.9%
Banks 3.6%
Machinery 3.5%
Electronic equipment, instruments & components 3.5%
Specialty retail 3.3%
Internet software & services 3.0%
Health care equipment & supplies 3.0%

Portfolio Holdings

(updated quarterly, upon availability)

Asset Mix

as of March 31, 2014 (updated monthly)

U.S. Equities 44.6%
Non-U.S. Equities 45.3%
U.S. Bonds 0.3%
Cash & Equivalents 9.8%

Geographic Breakdown

% of net assets as of March 31, 2014 (updated quarterly)

United States 44.9%
Europe 19.3%
Asia & Pacific Basin 21.4%
Other (Including Canada & Latin America) 4.6%
Cash & equivalents 9.8%

Assets and Portfolio Turnover (for fiscal years)

Fiscal Year Fund Assets (billions) Portfolio Turnover
2013 $24.4 37%
2012 $19.7 35%
2011 $17.1 39%
2010 $20.1 45%
2009 $17.5 56%

Assets shown are for combined share classes.

Largest Equity Holdings

Percent of net assets as of March 31, 2014 (updated monthly)

1.

Netflix

Internet subscription service for watching TV shows and movies.

1.3%
2.

Regeneron Pharmaceuticals

Biotechnology company focused on the treatment of serious medical conditions.

1.2%
3.

Incyte

Biotechnology company focused on developing small molecule drugs for oncology and inflammation.

0.9%
4.

Domino's Pizza

Major global pizza delivery chain.

0.9%
5.

ENN Energy Holdings

China-based operator of gas pipeline infrastructure and a distributor of piped and bottled gas.

0.8%
6.

Endo International

Provides specialty health care solutions.

0.8%
7.

Melco International Development

Engaged in the leisure and entertainment business in Hong Kong, Macau, China and the Philippines.

0.7%
8.

Lions Gate Entertainment

Independent motion picture and television producer and distributor.

0.7%
9.

Synageva BioPharma

Clinical stage biopharmaceutical company focused on life-threatening rare diseases and unmet medical needs.

0.7%
10.

Myriad Genetics

Biopharmaceutical company focused on diagnostic and therapeutic products to prevent and treat cancer and viral diseases.

0.7%

Portfolio Managers

Number of years with American Funds or affiliates
Julian N. Abdey 11
Mark E. Denning 31
Brady L. Enright 17
J. Blair Frank 19
Bradford F. Freer 20
Claudia P. Huntington 38
Jonathan Knowles 22
Lawrence Kymisis 11
Harold H. La 15
Andraz Razen 9
Gregory W. Wendt 26

(as of the prospectus dated December 1, 2013)

The portfolio managers shown are reflected in the fund’s most recent prospectus.

Important Legal Information

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries. Small-company stocks entail additional risks, and they can fluctuate in price more than larger company stocks.

Bond ratings, which typically range from AAA/Aaa (highest) to D (lowest), are assigned by credit rating agencies such as Standard & Poor's, Moody's and/or Fitch, as an indication of an issuer's creditworthiness.

* Investment results assume all distributions are reinvested and reflect applicable fees and expenses. Class F-2 shares were first offered on August 1, 2008. Class F-2 share results prior to the date of first sale are hypothetical based on Class A share results without a sales charge, adjusted for typical estimated expenses. View dates of first sale and specific expense adjustment information for Class F-2 shares.

  When applicable, investment results reflect fee waivers and/or expense reimbursements, without which results would have been lower. Read details about how waivers and/or reimbursements affect the results for each fund.

Source for Lipper expense ratio comparison: Lipper, based on institutional load funds, excluding funds of funds, for the most recent fiscal year-ends available as of March 31, 2014. Expenses are as of the fund’s prospectus. The expense ratios do not reflect sales charges or fees charged by financial intermediaries.

The SEC yield reflects the rate at which the fund is earning income on its current portfolio of securities, while the distribution rate reflects the fund's past dividends paid to shareholders. Accordingly, the fund's SEC yield and distribution rate may differ.


Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses, summary prospectuses and CollegeAmerica Program Description, which can be obtained from a financial professional and should be read carefully before investing. CollegeAmerica is distributed by American Funds Distributors® and sold through unaffiliated intermediaries.